» Articles » PMID: 26096795

Proteolytic Cleavage, Trafficking, and Functions of Nuclear Receptor Tyrosine Kinases

Overview
Journal FEBS J
Specialty Biochemistry
Date 2015 Jun 23
PMID 26096795
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Intracellular localization has been reported for over three-quarters of receptor tyrosine kinase (RTK) families in response to environmental stimuli. Internalized RTK may bind to non-canonical substrates and affect various cellular processes. Many of the intracellular RTKs exist as fragmented forms that are generated by γ-secretase cleavage of the full-length receptor, shedding, alternative splicing, or alternative translation initiation. Soluble RTK fragments are stabilized and intracellularly transported into subcellular compartments, such as the nucleus, by binding to chaperone or transcription factors, while membrane-bound RTKs (full-length or truncated) are transported from the plasma membrane to the ER through the well-established Rab- or clathrin adaptor protein-coated vesicle retrograde trafficking pathways. Subsequent nuclear transport of membrane-bound RTK may occur via two pathways, INFS or INTERNET, with the former characterized by release of receptors from the ER into the cytosol and the latter characterized by release of membrane-bound receptor from the ER into the nucleoplasm through the inner nuclear membrane. Although most non-canonical intracellular RTK signaling is related to transcriptional regulation, there may be other functions that have yet to be discovered. In this review, we summarize the proteolytic processing, intracellular trafficking and nuclear functions of RTKs, and discuss how they promote cancer progression, and their clinical implications.

Citing Articles

Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients.

Cheng T, Hung M, Wang L, Tu S, Wu C, Yen Y Biomark Res. 2025; 13(1):7.

PMID: 39789599 PMC: 11720525. DOI: 10.1186/s40364-024-00715-5.


Lineage-specific intersection of endothelin and GDNF signaling in enteric nervous system development.

Poltavski D, Cunha A, Tan J, Sucov H, Makita T Elife. 2024; 13.

PMID: 39641974 PMC: 11623925. DOI: 10.7554/eLife.96424.


Receptor tyrosine kinases in breast cancer treatment: unraveling the potential.

Qi Y, Deng S, Wang K Am J Cancer Res. 2024; 14(9):4172-4196.

PMID: 39417188 PMC: 11477839. DOI: 10.62347/KIVS3169.


ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity.

Mikulicic S, Shamun M, Massenberg A, Franke A, Freitag K, Doring T Front Immunol. 2024; 15:1335302.

PMID: 38370412 PMC: 10869470. DOI: 10.3389/fimmu.2024.1335302.


Nuclear translocation of Axl contributes to the malignancy of oral cancer cells.

Su Y, Shen P, Huang W, Hung Y, Huang T, Lin C J Dent Sci. 2024; 19(1):438-447.

PMID: 38303797 PMC: 10829653. DOI: 10.1016/j.jds.2023.08.014.


References
1.
Marti U, Ruchti C, Kampf J, Thomas G, Williams E, Peter H . Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. Thyroid. 2001; 11(2):137-45. DOI: 10.1089/105072501300042785. View

2.
Schlessinger J . Receptor tyrosine kinases: legacy of the first two decades. Cold Spring Harb Perspect Biol. 2014; 6(3). PMC: 3949355. DOI: 10.1101/cshperspect.a008912. View

3.
Myers J, Martins G, Ostrowski J, Stachowiak M . Nuclear trafficking of FGFR1: a role for the transmembrane domain. J Cell Biochem. 2003; 88(6):1273-91. DOI: 10.1002/jcb.10476. View

4.
Liccardi G, Hartley J, Hochhauser D . EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Res. 2011; 71(3):1103-14. PMC: 3033323. DOI: 10.1158/0008-5472.CAN-10-2384. View

5.
Kopitz C, Gerg M, Bandapalli O, Ister D, Pennington C, Hauser S . Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res. 2007; 67(18):8615-23. DOI: 10.1158/0008-5472.CAN-07-0232. View